Pricing Log in Create free account

Hyperfine, Inc. (HYPR) vs Microbot Medical Inc. (MBOT)

Hyperfine, Inc. and Microbot Medical Inc. are both Medical Devices companies. Hyperfine, Inc. and Microbot Medical Inc. are of similar size ($72.7M and $71.9M). Hyperfine, Inc. grew revenue faster over the last twelve months: 53.2% against −59.1%. Hyperfine, Inc. has the higher net margin (−210.8% vs −3,955.2%) and the higher return on invested capital (−401.8% vs −850.5%). Across the 18 metrics below, Hyperfine, Inc. leads on 10 and Microbot Medical Inc. on 8.

Valuation

Metric HYPR MBOT Medical Devices median
P/E n/m n/m 25.58
P/S 4.16 172.34 2.54
P/B 1.87 1.03 2.48
Price to free cash flow n/m n/m 28.81
EV/EBITDA n/m n/m 11.51
EV/Sales 2.26 15.01 2.72
Earnings yield (55.07%) (22.64%) (12.82%)
Free cash flow yield (39.98%) (25.18%) (8.18%)

Profitability

Metric HYPR MBOT Medical Devices median
Gross margin 51.41% (166.30%) 57.76%
Operating margin (203.27%) (4,480.03%) (15.07%)
Net margin (210.75%) (3,955.22%) (14.45%)
Free cash flow margin (166.48%) (4,340.11%) (3.88%)
Return on equity (96.97%) (32.91%) (10.35%)
Return on assets (64.40%) (30.68%) (17.26%)
Return on invested capital (401.79%) (850.51%) (5.27%)

Growth

Metric HYPR MBOT Medical Devices median
Revenue growth (TTM) 53.16% (59.09%) 10.41%
EPS growth (last fiscal year) 23.21% 60.27% 28.17%
Revenue growth, 5-year CAGR 115.18% 0.39% 15.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric HYPR MBOT Medical Devices median
Debt to equity 0.36 0.00 0.04
Current ratio 6.15 18.56 2.74
Net debt to EBITDA 1.00 5.35 0.54

Dividend

Metric HYPR MBOT Medical Devices median
Dividend yield — — 1.02%
Payout ratio — — 0.37

Size

Metric HYPR MBOT Medical Devices median
Market cap 72.69m 71.87m 239.53m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack